Georgina Tzanakaki (Greece)
University of West Attica National Meningitis Reference CenterAuthor Of 7 Presentations
Current progress and gaps in childhood vaccination to prevent IMD
What can we learn from meningococcal epidemiology?
Q&A
Round table discussion and expert perspectives on challenges in childhood IMD epidemiology, impact of the COVID-19 pandemic, vaccination trends and unmet needs
Discussion and live Q&A
Why is breadth of coverage so important for serogroup B vaccines?
Welcome and introduction
Presenter of 7 Presentations
What can we learn from meningococcal epidemiology?
Q&A
Round table discussion and expert perspectives on challenges in childhood IMD epidemiology, impact of the COVID-19 pandemic, vaccination trends and unmet needs
Discussion and live Q&A
Why is breadth of coverage so important for serogroup B vaccines?
Welcome and introduction
Current progress and gaps in childhood vaccination to prevent IMD
Moderator of 1 Session
Session Description:
This sponsored session will focus on raising awareness of the impact of childhood invasive meningococcal disease (IMD) and advances in preventative strategies. The distinguished faculty will provide expert perspectives on key challenges as well as discuss the most important unmet needs which still need to be addressed to reduce the burden of disease in infants, children and adolescents, and the impact on their families. This satellite symposium specifically intended for healthcare professionals (HCPs) is sponsored by Sanofi on the occasion of the 40th Annual Meeting of the European Society for Paediatric Infectious Diseases, 9-13 May 2021. Individual medicinal products that may be referred to during this session may not be authorised/licensed or available in all countries. Content, where applicable, is based on the European Summary of Product Characteristics (SmPC). Please consult prescribing information in your country of practice, current to the date of viewing this session, as information may vary from country-to-country.
Facilitator Of
Session Description:
This sponsored session will focus on raising awareness of the impact of childhood invasive meningococcal disease (IMD) and advances in preventative strategies. The distinguished faculty will provide expert perspectives on key challenges as well as discuss the most important unmet needs which still need to be addressed to reduce the burden of disease in infants, children and adolescents, and the impact on their families. This satellite symposium specifically intended for healthcare professionals (HCPs) is sponsored by Sanofi on the occasion of the 40th Annual Meeting of the European Society for Paediatric Infectious Diseases, 9-13 May 2021. Individual medicinal products that may be referred to during this session may not be authorised/licensed or available in all countries. Content, where applicable, is based on the European Summary of Product Characteristics (SmPC). Please consult prescribing information in your country of practice, current to the date of viewing this session, as information may vary from country-to-country.
Poster Author Of 2 e-Posters
EP053 - A POPULATION-BASED STUDY REVEALS SIGNIFICANT REDUCTION OF INFLUENZA AND INVASIVE MENINGOCOCCAL DISEASE AMONG GREEK CHILDREN DURING THE COVID-19 PANDEMIC (ID 636)
- Danai Ktena (Greece)
- Eleni Kourkouni (Greece)
- Flora Kontopidou (Greece)
- Kassiani Gkolfinopoulou (Greece)
- Kalliopi Papadima (Greece)
- Theano Georgakopoulou (Greece)
- Ioanna Magaziotou (Greece)
- Anastasia Andreopoulou (Greece)
- Georgina Tzanakaki (Greece)
- Theoklis Zaoutis (Greece)
- Vassiliki Papaevangelou (Greece)
